Cargando…

Cyclin D1 and Ki-67 expression and its correlation with histopathological parameters and cervical lymph node metastasis in oral squamous cell carcinoma

BACKGROUND: Oral squamous cell carcinoma (OSCC) is the most common malignant tumor among oral cancers. Cyclin D1 and Ki-67 have associated with cell division. The aim of this study was to compare the expression of these markers in OSCC with and without cervical lymph node (LN) metastasis. MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khalesi, Saeedeh, Maleki, Laleh, Eskandari, Shahnaz, Dehabadi, Foad Zare, Kohpaee, Amirhossein Yousefi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680078/ https://www.ncbi.nlm.nih.gov/pubmed/38020247

Ejemplares similares

Human papillomavirus in oral squamous cell carcinoma using p16 and its co-relationship with cervical lymph node metastasis and clinicopathological parameters
por: Khalesi, Saeedeh, et al.
Publicado: (2023)

Ki-67 Expression in CRC Lymph Node Metastasis Does Not Predict Survival
por: Martins, Sandra F., et al.
Publicado: (2015)

Evaluation of Epstein–Barr virus expression in oral squamous cell carcinomas
por: Khalesi, Saeedeh, et al.
Publicado: (2022)

The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer
por: Lindfors, Helene, et al.
Publicado: (2021)

Immunoexpression of Ki67, p53 and cyclin D1 in osteosarcomas
por: Niculescu, Ştefan Adrian, et al.
Publicado: (2021)

Differential Expression of RAGE, EGFR and Ki-67 in Primary Tumors and Lymph Node Deposits of Breast Carcinoma
por: Aboushousha, Tarek, et al.
Publicado: (2018)

Invited Commentary: The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer
por: Barczyński, Marcin
Publicado: (2021)

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer
por: Lindfors, Helene, et al.
Publicado: (2023)

Cyclin D1 and Ki-67 expression in normal, hyperplastic and neoplastic endometrium
por: Shevra, CR, et al.
Publicado: (2015)

The role of cyclin D1 and Ki‐67 in the development and prognostication of thin melanoma
por: Kaufmann, Corina, et al.
Publicado: (2020)

Evaluation of changes in Salivary Lactate Dehydrogenase Level for detection of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis Study
por: Abedi, Niloufar, et al.
Publicado: (2023)

Cyclin D1 and Ki-67 expression correlates to tumor staging in tongue squamous cell carcinoma
por: Guimarães, Eduardo-Pereira, et al.
Publicado: (2015)

Immunohistochemical Expression of Cyclin D1 and Ki-67 in Primary and Metastatic Oral Squamous Cell Carcinoma
por: Nazar, Maryam, et al.
Publicado: (2020)

Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients
por: ALCO, GUL, et al.
Publicado: (2015)

Histopathological Spectrum of Meningiomas with Emphasis on Prognostic Role of Ki67 Labelling Index
por: Solanke, Girish, et al.
Publicado: (2020)

Prognostic Value of Ki-67 in Breast Cancer Patients with Positive Axillary Lymph Nodes: A Retrospective Cohort Study
por: Li, Feng-yan, et al.
Publicado: (2014)

Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer
por: Aziz, Sura, et al.
Publicado: (2016)

Flow Cytometric Assessment of Ki-67 Expression in Lymphocytes From Physiologic Lymph Nodes, Lymphoma Cell Populations and Remnant Normal Cell Populations From Lymphomatous Lymph Nodes
por: Rütgen, Barbara C., et al.
Publicado: (2021)

Ki-67 immunostaining in astrocytomas: Association with histopathological grade – A South Indian study
por: Shivaprasad, Nandish Vastrad, et al.
Publicado: (2016)

Association between Ki-67 Labeling index and Histopathological Grading of Glioma in Indonesian Population
por: Theresia, Emilia, et al.
Publicado: (2020)

Proposal for a New Diagnostic Histopathological Approach in the Evaluation of Ki-67 in GEP-NETs
por: Faviana, Pinuccia, et al.
Publicado: (2022)

Intra-tumoral distribution of Ki-67 and Cyclin D1 in ER+ mammary carcinoma: quantitative evaluation
por: Latifa, Mohammedi, et al.
Publicado: (2021)

Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients
por: Hao, Junmei, et al.
Publicado: (2021)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Prognostic value of SOX2, Cyclin D1, P53, and ki-67 in patients with esophageal squamous cell carcinoma
por: Wang, Hui, et al.
Publicado: (2018)

Comparative Analysis of the Histopathologic Features, β-Catenin, and Ki67 Expression between Fibromatosis and Fibrosarcoma
por: Deyhimi, Parviz, et al.
Publicado: (2019)

Evaluation of Ki-67 Expression in Oral Submucous Fibrosis and Its Correlation with Clinical and Histopathological Features
por: Iqbal, Asif, et al.
Publicado: (2019)

The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer
por: Klintman, Marie, et al.
Publicado: (2013)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Immunodetectable cyclin D (1) is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions
por: Shoker, B S, et al.
Publicado: (2001)

Diagnostic utility of Ki-67 and Cyclin D1 immunostaining in differentiation of psoriasis vs. other psoriasiform dermatitis
por: Sezer, Engin, et al.
Publicado: (2015)

Expression of FOXC2, PinX1, Ki-67 and Cyclin D1 in cutaneous cell carcinoma
por: Zhao, Haiying, et al.
Publicado: (2017)

Changes in the Ki‐67 labeling index between primary breast cancer and metachronous metastatic axillary lymph node: A retrospective observational study
por: Ishibashi, Naoya, et al.
Publicado: (2018)

Prediction model of axillary lymph node status using automated breast ultrasound (ABUS) and ki-67 status in early-stage breast cancer
por: Wang, Qiucheng, et al.
Publicado: (2022)

The Value of Ki-67 Labeling Index in Central Lymph Node Metastasis and Survival of Papillary Thyroid Carcinoma: Evidence From the Clinical and Molecular Analyses
por: Lei, Yi, et al.
Publicado: (2023)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Does immunohistochemical staining of P53, Ki 67 and cyclin A accurately predict Wilms tumor recurrence and survival?
por: Atwa, Ahmed M, et al.
Publicado: (2022)

Correlation between the Expression of VEGF and Ki67 and Lymph Node Metastasis in Non-small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Wei, Dong, et al.
Publicado: (2022)

Immunoexpression of Ki-67, MCM2, and MCM3 in Ameloblastoma and Ameloblastic Carcinoma and Their Correlations with Clinical and Histopathological Patterns
por: Carreón-Burciaga, Ramón Gil, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mv2apr8j3hn9cbh020e9rtmve7